Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 205404
Company: SAGENT PHARMS INC
Company: SAGENT PHARMS INC
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| METHOCARBAMOL | METHOCARBAMOL | 1GM/10ML (100MG/ML) | SOLUTION;IM-IV | Prescription | AP | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 07/18/2017 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |
METHOCARBAMOL
SOLUTION;IM-IV; 1GM/10ML (100MG/ML)
TE Code = AP
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| METHOCARBAMOL | METHOCARBAMOL | 1GM/10ML (100MG/ML) | SOLUTION;IM-IV | Prescription | No | AP | 207496 | AM REGENT |
| METHOCARBAMOL | METHOCARBAMOL | 1GM/10ML (100MG/ML) | SOLUTION;IM-IV | Prescription | No | AP | 206128 | EUGIA PHARMA |
| METHOCARBAMOL | METHOCARBAMOL | 1GM/10ML (100MG/ML) | SOLUTION;IM-IV | Prescription | No | AP | 209331 | FRESENIUS KABI USA |
| METHOCARBAMOL | METHOCARBAMOL | 1GM/10ML (100MG/ML) | SOLUTION;IM-IV | Prescription | No | AP | 211504 | GLAND |
| METHOCARBAMOL | METHOCARBAMOL | 1GM/10ML (100MG/ML) | SOLUTION;IM-IV | Prescription | No | AP | 205354 | MONTEREY PHARMS LLC |
| METHOCARBAMOL | METHOCARBAMOL | 1GM/10ML (100MG/ML) | SOLUTION;IM-IV | Prescription | No | AP | 205404 | SAGENT PHARMS INC |
| METHOCARBAMOL | METHOCARBAMOL | 1GM/10ML (100MG/ML) | SOLUTION;IM-IV | Prescription | No | AP | 208116 | SLATE RUN PHARMA |
| METHOCARBAMOL | METHOCARBAMOL | 1GM/10ML (100MG/ML) | SOLUTION;IM-IV | Prescription | No | AP | 207522 | SOMERSET THERAPS LLC |
| ROBAXIN | METHOCARBAMOL | 1GM/10ML (100MG/ML) | SOLUTION;IM-IV | Prescription | Yes | AP | 011790 | HIKMA |